Company / Book Value per Share
Ultragenyx Pharmaceutical Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.865
FY2025
5-year range
-$0.865 / $9.784
FY2021-FY2025
Trend
-127.9%
vs FY2024
Sector context
#199 of 209
Health Care
What the data says
Among 209 Health Care companies, Ultragenyx Pharmaceutical Inc. is in the bottom 5% for book value per share. Book Value per Share has declined for 5 consecutive years, from $10.528 in FY2020 to -$0.865 in FY2025.
Based on SEC 10-K filings.
-$0.865 in FY2025.
Declined from $3.918 to -$0.865 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 209This company -$0.865 Sector average $189.406
▼
-100.5% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s book value per share has declined for 5 consecutive years.
- In FY2025, book value per share decreased 127.9% year-over-year.
- Ranks #199 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.865 | -127.9% |
| FY2024 | $3.098 | -20.9% |
| FY2023 | $3.918 | -22.8% |
| FY2022 | $5.076 | -48.1% |
| FY2021 | $9.784 | -7.1% |
| FY2020 | $10.528 | +39.6% |
| FY2019 | $7.539 | -45.3% |
| FY2018 | $13.786 | +7.1% |
| FY2017 | $12.878 | +170.7% |
| FY2016 | $4.757 | -67.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026